Schaeffeler E - Search Results

1

Jäger S, Schricker S, Tremmel R, Schaeffeler E, Schwab M. Jäger S, et al. Among authors: schaeffeler e. Dtsch Med Wochenschr. 2021 Jan;146(1):23-29. doi: 10.1055/a-1109-0814. Epub 2021 Jan 4. Dtsch Med Wochenschr. 2021. PMID: 33395723 German.

2

[Therapy of chronic inflammatory bowel diseases with azathioprine, 6-mercaptopurine and 6-thioguanine. Clinico-pharmacologic aspects].

Schwab M, Herrlinger K, Schaeffeler E, Stange EF. Schwab M, et al. Among authors: schaeffeler e. Dtsch Med Wochenschr. 2003 Feb 21;128(8):378-85. doi: 10.1055/s-2003-37378. Dtsch Med Wochenschr. 2003. PMID: 12594624 Review. German. No abstract available.

3

CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-time PCR.

Schaeffeler E, Schwab M, Eichelbaum M, Zanger UM. Schaeffeler E, et al. Hum Mutat. 2003 Dec;22(6):476-85. doi: 10.1002/humu.10280. Hum Mutat. 2003. PMID: 14635107

4

CYP2C19 polymorphism is a major predictor of treatment failure in white patients by use of lansoprazole-based quadruple therapy for eradication of Helicobacter pylori.

Schwab M, Schaeffeler E, Klotz U, Treiber G. Schwab M, et al. Among authors: schaeffeler e. Clin Pharmacol Ther. 2004 Sep;76(3):201-9. doi: 10.1016/j.clpt.2004.05.002. Clin Pharmacol Ther. 2004. PMID: 15371981

5

Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing.

Teml A, Schaeffeler E, Herrlinger KR, Klotz U, Schwab M. Teml A, et al. Among authors: schaeffeler e. Clin Pharmacokinet. 2007;46(3):187-208. doi: 10.2165/00003088-200746030-00001. Clin Pharmacokinet. 2007. PMID: 17328579 Review.

6

Pretreatment determination of TPMT--state of the art in clinical practice.

Teml A, Schaeffeler E, Schwab M. Teml A, et al. Among authors: schaeffeler e. Eur J Clin Pharmacol. 2009 Mar;65(3):219-21. doi: 10.1007/s00228-009-0618-7. Epub 2009 Feb 7. Eur J Clin Pharmacol. 2009. PMID: 19198820 No abstract available.

7

[Pharmacogenomics: hype or hope?].

Schwab M, Schaeffeler E, Zanger UM, Brauch H, Kroemer HK. Schwab M, et al. Among authors: schaeffeler e. Dtsch Med Wochenschr. 2011 Mar;136(10):461-7. doi: 10.1055/s-0031-1274528. Epub 2011 Mar 1. Dtsch Med Wochenschr. 2011. PMID: 21365522 Review. German.

8

Warfarin pharmacogenetics meets clinical use.

Schwab M, Schaeffeler E. Schwab M, et al. Among authors: schaeffeler e. Blood. 2011 Sep 15;118(11):2938-9. doi: 10.1182/blood-2011-07-367763. Blood. 2011. PMID: 21921056 Free article. No abstract available.

9

Mammalian MATE (SLC47A) transport proteins: impact on efflux of endogenous substrates and xenobiotics.

Damme K, Nies AT, Schaeffeler E, Schwab M. Damme K, et al. Among authors: schaeffeler e. Drug Metab Rev. 2011 Nov;43(4):499-523. doi: 10.3109/03602532.2011.602687. Epub 2011 Sep 17. Drug Metab Rev. 2011. PMID: 21923552 Review.

10

Organic anion transporters and their implications in pharmacotherapy.

Emami Riedmaier A, Nies AT, Schaeffeler E, Schwab M. Emami Riedmaier A, et al. Among authors: schaeffeler e. Pharmacol Rev. 2012 Jul;64(3):421-49. doi: 10.1124/pr.111.004614. Epub 2012 Mar 28. Pharmacol Rev. 2012. PMID: 22457399 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

200 results

Search Page